As part of its advocacy program in Europe, ACRO submits regulatory comments to European officials. This comment letter, submitted by ACRO to the European Commission on January 29, 2026, regarding the EMA Reflection paper on patient experience data can be found below. ACRO offers feedback on this reflection paper emphasizing the importance of incorporation of patient experience data throughout clinical development.